📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Alkermes Plc

Common Name
Alkermes
Country
Ireland
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,800
Ticker
ALKS
Exchange
NASDAQ/NGS
Description
Alkermes plc is a prominent biopharmaceutical company focusing on the development and commercialization of innovative medicines aimed at addressing unmet medical needs in major therapeutic areas such ...

Alkermes's GHG Emissions Data Preview

In 2023, Alkermes completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Alkermes has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=ALKS&reporting_period=2024"

Verified Sources Behind Alkermes’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Alkermes’s data sources below and access millions more through our Disclosure Search.

a. Alkermes's Corporate Responsibility Report (CRR) 2024
a. Alkermes's Corporate Responsibility Report (CRR) 2024

Insights into Alkermes's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions ofAlkermes amounted to46,320.264metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Alkermesdecreased by 5.85%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a

Alkermes's Scope 1 Emissions Over Time

2019202020212022202304.5 k9 k13.5 k18 ktCO2e-9%+11%+13%-9%
  • Total Scope 1
  • Year-over-Year Change

What are Alkermes's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Alkermes were 14,762.887 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

Has Alkermes reduced its Scope 1 emissions over time?

Since 2019, Alkermes's Scope 1 emissions have increased by 3.47%, reflecting a rising long-term trend in Scope 1 emissions over time.a

Compared to the previous year(2022), Alkermes's Scope 1 emissions decreased by 9.14%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a

What are Alkermes's Scope 2 emissions?

In 2023, Alkermes reported Scope 2 greenhouse gas (GHG) emissions of 31,557.377 tCOâ‚‚e without specifying the calculation method.a

Has Alkermes reduced its Scope 2 emissions over time?

Since 2019, Alkermes's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method)have remained relatively stable, indicating that Alkermes's emissions have plateaued with no significant change in its energy consumption footprint.a

Compared to the previous year(2022), Alkermes's Scope 2 emissions(Unspecified Calculation Method) have remained relatively stable, indicating that Alkermes's emissions have plateaued with no significant change in its energy consumption footprint.a

What methodology does Alkermes use for Scope 2 reporting?

In 2023, Alkermes reported its Scope 2 emissions using an unspecified methodology.a

Alkermes's Scope 2 Emissions Over Time

2019202020212022202308.5 k17 k25.5 k34 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Alkermes’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Alkermes reported Scope 1 greenhouse gas (GHG) emissions of 14,762.887 tCOâ‚‚e and total revenues of USD 1,663 millions. This translates into an emissions intensity of 8.88 tCOâ‚‚e per millions USD.a

Alkermes's Scope 1 Emissions Intensity Compared to Peers

2002,00010,000100,000500,000Scope 1 Emissions (tCO2e)2005001,0002,00010,000Revenues (Millions of USD)ADNJSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MHisamitsu PharmaceuticalYear: 2022Scope 1: 7,862 tCO2eRevenue: $M 1,040Scope 1 Intensity: 7.56 tCO2e/$MSawai Group HoldingsYear: 2023Scope 1: 19,500 tCO2eRevenue: $M 1,229Scope 1 Intensity: 15.87 tCO2e/$MHikma PharmaceuticalsYear: 2024Scope 1: 38,468 tCO2eRevenue: $M 2,307Scope 1 Intensity: 16.67 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MH LundbeckYear: 2024Scope 1: 20,409 tCO2eRevenue: $M 3,067Scope 1 Intensity: 6.66 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MGedeon RichterYear: 2024Scope 1: 45,632 tCO2eRevenue: $M 2,171Scope 1 Intensity: 21.02 tCO2e/$MAAApeloa PharmaceuticalYear: 2024Scope 1: 10,400 tCO2eRevenue: $M 1,647Scope 1 Intensity: 6.31 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MTsumura & CoYear: 2021Scope 1: 39,385 tCO2eRevenue: $M 1,055Scope 1 Intensity: 37.32 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MNNNippon ShinyakuYear: 2023Scope 1: 4,366 tCO2eRevenue: $M 1,082Scope 1 Intensity: 4.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MSwedish Orphan BiovitrumYear: 2024Scope 1: 1,097 tCO2eRevenue: $M 2,362Scope 1 Intensity: 0.46 tCO2e/$MIpsenYear: 2024Scope 1: 9,932 tCO2eRevenue: $M 3,720Scope 1 Intensity: 2.67 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MGranules IndiaYear: 2024Scope 1: 58,254 tCO2eRevenue: $M 538Scope 1 Intensity: 108.19 tCO2e/$MAlkermesYear: 2023Scope 1: 14,763 tCO2eRevenue: $M 1,663Scope 1 Intensity: 8.88 tCO2e/$M

How does Alkermes's GHG emissions intensity compare to its peers?

In 2023, Alkermes reported a Scope 1 emissions intensity of 8.88 tCOâ‚‚e per millions USD. Compared to the peer group median of 16.27, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Alkermes rank on GHG emissions intensity within its industry?

In 2023, Alkermes ranked 9 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a

Alkermes is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to Alkermes's GHG Emissions Dataset?
Sign Up